The SearchLight DNA™
SearchLight DNA is fueled by the world's most comprehensive canine genomic database, encompassing billions of data points and hundreds of thousands of unique variants, a truly unparalleled resource for canine cancer genomics. More than just a database, it's a living, growing resource, constantly enriched with new data to enhance our understanding of canine cancer.
SearchLight DNA analyzes a 120 gene panel
This expanded coverage, when compared to similar genomic tests provides:
Enhanced Diagnostic Accuracy in Complex Cases
Every cancer case is unique. Analyzing more genes increases the chances of identifying key mutations that are specific to certain cancer types.
More Comprehensive Prognostic Information
Many genes can influence prognosis. Our panel covers a wider range of mutations associated with clinical outcomes.
Increased Identification of Therapeutic Targets
Precision medicine is about targeting specific mutations with tailored therapies. Our panel significantly expands the possibilities for personalized treatment strategies for our dogs.
300+ Billion Datapoints powering SearchLight DNA
SearchLight DNA.s datapoints aren't just a number - they represent the largest dataset of its kind. This advantage is not just about numbers; it's about:
The Ability to Detect Subtle Genomic Nuances
The massive amounts of data reveal patterns and insights that smaller ones miss.
Ultimately, Better Care for Your Patients
Data superiority translates to superior clinical utility for veterinarians and their canine patients.
More Confident Clinical Interpretations
Our data provides a stronger foundation for every interpretation we deliver.
SearchLight DNA is based on cutting edge science in both humans and dogs
5000
dogs, discussed in
145
articles describing mutation- based associations, yielding
1400
biomarker associations
10,000+
individuals, discussed in
400
articles describing mutation- based associations, yielding
1000
"caninized" biomarker associations
Developed with world leaders
SearchLight DNA was developed with The Translational Genomics Research Institute (TGen, an affiliate of City of Hope), who are leaders in the genomics revolution. Launched by Dr. Jeffrey M. Trent, the founding Scientific Director of the Human Genome Project, this world-class research institute explores the most advanced areas of genetics in human and animal health.